Active Ingredient History
There is no available sources on the medical use of platinum iodide. The salt is insoluble. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Ovarian Neoplasms (approved 1978)
Testicular Neoplasms (approved 1978)
Urinary Bladder Neoplasms (approved 1978)
Abdominal Neoplasms (Phase 2)
Acquired Immunodeficiency Syndrome (Phase 2)
Acute Kidney Injury (Phase 2)
Adenocarcinoma (Phase 4)
Adenocarcinoma of Lung (Phase 4)
Adenoma, Islet Cell (Phase 2)
Adrenal Gland Neoplasms (Phase 3)
Adrenocortical Carcinoma (Phase 3)
Albumin-Bound Paclitaxel (Phase 1/Phase 2)
Anemia (Phase 4)
Angiogenesis Modulating Agents (Phase 2)
Anterior Cruciate Ligament Injuries (Phase 2)
Antineoplastic Agents (Phase 2)
Anus Neoplasms (Phase 3)
Anxiety Disorders (Phase 2)
Appendiceal Neoplasms (Phase 1)
Ascites (Phase 2)
Astrocytoma (Phase 1)
Bevacizumab (Phase 2)
Bile Duct Neoplasms (Phase 3)
Biliary Tract Neoplasms (Phase 3)
Biomarkers (Phase 2)
Bone Marrow Diseases (Phase 2)
Brain Neoplasms (Phase 3)
BRCA1 Protein (Phase 2)
Breast Neoplasms (Phase 3)
Breast Neoplasms, Male (Phase 1)
Brenner Tumor (Phase 1)
Bronchial Diseases (Phase 3)
Burkitt Lymphoma (Phase 1/Phase 2)
Carboplatin (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Adenosquamous (Phase 2)
Carcinoma, Basal Cell (Phase 1/Phase 2)
Carcinoma, Bronchogenic (Phase 3)
Carcinoma, Endometrioid (Phase 1)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Mucoepidermoid (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Small Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 4)
Carcinoma, Transitional Cell (Phase 3)
Carcinoma, Verrucous (Phase 3)
Cardiotoxicity (Phase 3)
Central Nervous System Neoplasms (Phase 3)
Chemical and Drug Induced Liver Injury (Phase 4)
Chemoradiotherapy (Phase 3)
Chemotherapy, Adjuvant (Phase 3)
Child (Phase 2)
Cholangiocarcinoma (Phase 3)
Chondrosarcoma (Phase 1/Phase 2)
Choriocarcinoma (Phase 3)
Choroid Plexus Neoplasms (Phase 3)
Circulating Tumor DNA (Phase 2)
Cisplatin (Phase 3)
Clonal Hematopoiesis (Phase 2)
Cognition Disorders (Phase 3)
Colitis, Ulcerative (Phase 1/Phase 2)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 3)
Cyclophosphamide (Phase 2)
Cytoreduction Surgical Procedures (Phase 2)
Death (Phase 2)
Depression (Phase 2)
Desmoplastic Small Round Cell Tumor (Phase 1)
Dexamethasone (Phase 2)
Digestive System Diseases (Phase 1/Phase 2)
Digestive System Neoplasms (Phase 2)
Disease-Free Survival (Phase 2/Phase 3)
Disease Progression (Phase 2)
Drug Evaluation (Phase 2)
Drugs, Investigational (Phase 3)
Drug Therapy (Phase 3)
Drug Therapy, Combination (Phase 1/Phase 2)
Endocrine Gland Neoplasms (Phase 1/Phase 2)
Endocrine System Diseases (Phase 1/Phase 2)
Endodermal Sinus Tumor (Phase 3)
Endometrial Neoplasms (Phase 3)
Endothelium (Phase 2)
Enteral Nutrition (Phase 3)
Enteropathy-Associated T-Cell Lymphoma (Phase 2)
Ependymoma (Phase 3)
Epidermal Growth Factor (Phase 2)
Epstein-Barr Virus Infections (Phase 2/Phase 3)
Esophageal Diseases (Phase 2)
Esophageal Neoplasms (Phase 4)
Esophageal Squamous Cell Carcinoma (Phase 3)
Esophagogastric Junction (Phase 2)
Fallopian Tube Neoplasms (Phase 3)
Fatigue (Phase 2)
Gallbladder Neoplasms (Phase 3)
Ganglioneuroblastoma (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Gastrointestinal Stromal Tumors (Phase 2)
General Surgery (Phase 3)
Genes, erbB-1 (Phase 2)
Genes, erbB-2 (Phase 1)
Genital Neoplasms, Female (Phase 2)
Genital Neoplasms, Male (Phase 2)
Germinoma (Phase 3)
Gestational Trophoblastic Disease (Phase 3)
Glioblastoma (Phase 1/Phase 2)
Glioma (Phase 3)
Graft vs Host Disease (Phase 2)
Hamartoma (Phase 3)
Head and Neck Neoplasms (Phase 4)
Hepatoblastoma (Phase 3)
Histone Deacetylase Inhibitors (Phase 2)
HIV Infections (Phase 2)
Hodgkin Disease (Phase 3)
Human papillomavirus 16 (Phase 2)
Hydatidiform Mole (Phase 3)
Hypopharyngeal Neoplasms (Phase 3)
Hypoxia (Phase 2)
Hysterectomy (Phase 2)
Immune Checkpoint Inhibitors (Phase 3)
Immune System Diseases (Phase 2)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Immunoglobulin Light Chains (Phase 2)
Immunoproliferative Disorders (Phase 2)
Immunotherapy (Phase 3)
Induction Chemotherapy (Phase 1)
Inflammatory Breast Neoplasms (Phase 3)
Intestinal Diseases (Phase 1/Phase 2)
Intestinal Neoplasms (Phase 2)
Kidney Failure, Chronic (Phase 1)
Kidney Neoplasms (Phase 2)
Klatskin Tumor (Phase 3)
Laparoscopy (Phase 2)
Laparotomy (Phase 2)
Lapatinib (Phase 2)
Laryngeal Neoplasms (Phase 3)
Leukemia (Phase 2)
Lip Neoplasms (Phase 2)
Liver Cirrhosis (Phase 3)
Liver Diseases (Phase 2)
Liver Neoplasms (Phase 3)
Lung (Phase 2)
Lung Diseases (Phase 3)
Lung Neoplasms (Phase 4)
Lymphatic Diseases (Phase 2)
Lymphatic Metastasis (Phase 3)
Lymphohistiocytosis, Hemophagocytic (Phase 4)
Lymphoma (Phase 3)
Lymphoma, AIDS-Related (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 1/Phase 2)
Lymphoma, Follicular (Phase 1/Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 4)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 4)
Lymphoma, T-Cell, Peripheral (Phase 4)
Lymphoproliferative Disorders (Phase 2)
Malaria (Phase 3)
Mediastinal Neoplasms (Phase 3)
Medical Oncology (Phase 1)
Medulloblastoma (Phase 3)
Melanoma (Phase 4)
Mesothelioma (Phase 3)
Mesothelioma, Malignant (Phase 3)
Mouth (Phase 3)
Mouth Neoplasms (Phase 3)
Mucositis (Phase 3)
Multiple Myeloma (Phase 3)
Mutation (Phase 3)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 1/Phase 2)
Nasal Cavity (Phase 2)
Nasopharyngeal Carcinoma (Phase 3)
Nasopharyngeal Diseases (Phase 3)
Nasopharyngeal Neoplasms (Phase 3)
Nausea (Phase 3)
Neoadjuvant Therapy (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasm Recurrence, Local (Phase 3)
Neoplasms (Phase 4)
Neoplasms by Histologic Type (Phase 3)
Neoplasms by Site (Phase 3)
Neoplasms, Connective and Soft Tissue (Phase 2/Phase 3)
Neoplasms, Connective Tissue (Phase 2/Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 4)
Neoplasms, Glandular and Epithelial (Phase 1/Phase 2)
Neoplasms, Nerve Tissue (Phase 3)
Neoplasms, Squamous Cell (Phase 3)
Neoplasms, Unknown Primary (Phase 2)
Neuroblastoma (Phase 3)
Neuroectodermal Tumors (Phase 3)
Neuroectodermal Tumors, Primitive (Phase 2)
Neuroendocrine Tumors (Phase 2/Phase 3)
Neurotoxicity Syndromes (Phase 1)
Neutropenia (Phase 2)
Nutrition Therapy (Phase 3)
Oncogenes (Phase 1)
Oropharyngeal Neoplasms (Phase 4)
Osteosarcoma (Phase 3)
Ototoxicity (Phase 3)
Ovarian Diseases (Phase 2)
Ovarian Neoplasms (Phase 3)
Pain (Phase 3)
Pancreatic Diseases (Phase 1/Phase 2)
Pancreatic Neoplasms (Phase 4)
Papillomaviridae (Phase 2)
Papillomavirus Infections (Phase 2)
Paranasal Sinuses (Phase 2)
Paranasal Sinus Neoplasms (Phase 3)
Pathology (Phase 2)
Pediatrics (Phase 3)
Penile Neoplasms (Phase 2)
Perioperative Period (Phase 2)
Peritoneal Neoplasms (Phase 3)
Peritoneum (Phase 2)
Pharmacology (Phase 3)
Pharyngeal Diseases (Phase 1/Phase 2)
Pharyngeal Neoplasms (Phase 3)
Pheochromocytoma (Phase 2)
Plasmacytoma (Phase 2)
Pleura (Phase 2)
Pleural Effusion, Malignant (Phase 3)
Pleural Neoplasms (Phase 2)
Precancerous Conditions (Phase 3)
Progression-Free Survival (Phase 3)
Prostatic Neoplasms (Phase 3)
Prosthesis Failure (Phase 3)
Quality of Life (Phase 3)
Radiation (Phase 3)
Radiation Oncology (Phase 2)
Radiosurgery (Phase 2)
Radiotherapy (Phase 3)
ras Proteins (Phase 2)
Receptors, Fibroblast Growth Factor (Phase 3)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 3)
Respiratory Tract Diseases (Phase 3)
Respiratory Tract Neoplasms (Phase 3)
Retinoblastoma (Phase 3)
Retroperitoneal Neoplasms (Phase 1)
Rhabdoid Tumor (Phase 3)
Rhabdomyosarcoma (Phase 2)
Rituximab (Phase 2)
Salivary Gland Neoplasms (Phase 3)
Sarcoma (Phase 3)
Sarcoma, Ewing (Phase 2)
Seminoma (Phase 3)
Sentinel Lymph Node (Phase 2)
Skin Neoplasms (Phase 3)
Small Cell Lung Carcinoma (Phase 4)
Squamous Cell Carcinoma of Head and Neck (Phase 4)
Stomach Diseases (Phase 1)
Stomach Neoplasms (Phase 3)
Stomatitis (Phase 3)
Survival (Phase 3)
Teratoma (Phase 3)
Testicular Neoplasms (Phase 3)
Therapeutics (Phase 2)
Thoracic Neoplasms (Phase 3)
Thrombocytopenia (Phase 2)
Thymidylate Synthase (Phase 2)
Thymoma (Phase 3)
Thyroid Carcinoma, Anaplastic (Phase 1/Phase 2)
Thyroid Neoplasms (Phase 2)
Tongue Neoplasms (Phase 3)
Triple Negative Breast Neoplasms (Phase 3)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Urogenital Neoplasms (Phase 2)
Urologic Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 4)
Uterine Neoplasms (Phase 3)
Vaginal Neoplasms (Phase 2)
Vinorelbine (Phase 2)
Vulvar Neoplasms (Phase 3)
Waldenstrom Macroglobulinemia (Phase 2)
Wilms Tumor (Phase 1)
Xerostomia (Phase 2)
Yang Deficiency (Phase 2)
Yin Deficiency (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
